Drugs / Pergolide
Pergolide
also known as
Celance · LY 127809 · NSC-319773 · NSC-758442 · pergolid · Pergolida · Pergolide mesilate · PERGOLIDE MESYLATE · +2 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PERMAX | — | 1988-12-30 | fda.gov ↗ |
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00000269 | Oct 1995 → Dec 2001 | cocaine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000215 | ? → Dec 2001 | cocaine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00000248 | Feb 1996 → ? | cocaine dependence | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00102284 | Mar 2004 → Apr 2005 | — | University Hospital Muenster | Terminated | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT01066403 | Oct 2003 → Mar 2008 | schizophrenia | Heidelberg University | Completed | No outcome recorded |
| — | NCT00252044 | Oct 2000 → ? | schizotypal personality disorder | Bronx VA Medical Center | Unknown | No outcome recorded |
| — | NCT00004433 | Dec 1994 → Sep 2002 | Tourette syndrome | Children's Hospital Medical Center, Cincinnati | Completed | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT00624741 | — | Parkinson disease | Bausch Health Americas, Inc. | No longer available | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2002-11-27 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approval of Pergolide Mesylate Tablets tevapharm.com ↗ |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pergolide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00624741 ↗ |
| Known as | Celance | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | LY 127809 | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | NSC-319773 | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | NSC-758442 | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | pergolid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00102284 ↗ |
| Known as | Pergolida | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | Pergolide mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | PERGOLIDE MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | Pergolide methanesulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Known as | Permax | ChEMBL registry synonym — accepted as the source's own label CHEMBL531 ↗ |
| Action | Activate | “Subjects received the tonically stimulating dopamine-receptor agonist pergolide (0.1 mg) vs placebo 120 min before training on each training day.” PMID 16880771 ↗ Jul 2006 |
| Modality | Small molecule | — CHEMBL531 ↗ |
| Route | Oral | “receive oral pergolide” NCT00004433 ↗ |